Peak Bio, Inc. Warrant
PKBOW
PKBOW was delisted on the 5th of January, 2023.
17 hedge funds and large institutions have $701K invested in Peak Bio, Inc. Warrant in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
6% more funds holding
Funds holding: 16 → 17 (+1)
26% less capital invested
Capital invested by funds: $948K → $701K (-$247K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
+$7.98K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$32 |
| 3 |
CS
Clear Street
New York
|
+$2 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
-$9K |
| 2 |
ICMH
Integrity Capital Management (HK)
Central,
Hong Kong
|
-$3K |
| 3 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$1.28K |
| 4 |
SCM
Shaolin Capital Management
Miami,
Florida
|
-$870 |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$383 |
PKBOW Hedge Fund Activity: Q2 2022 in Review
17 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Peak Bio, Inc. Warrant (PKBOW) for Q2 2022, worth a combined $701K — down 26% from $948K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new PKBOW positions and 2 closed out — a net gain of 1 holder — while 0 added to existing stakes and 3 trimmed.
The largest buyer was Yakira Capital Management, opening a new position worth an estimated $7.98K. The largest seller was Picton Mahoney Asset Management, exiting entirely with an estimated $9K sold.
- 17 institutional investors held Peak Bio, Inc. Warrant (PKBOW) as of Q2 2022, up from 16 in Q1 2022.
- Funds reported $701K of Peak Bio, Inc. Warrant stock for Q2 2022, down 26% quarter-over-quarter.
- 3 funds opened new Peak Bio, Inc. Warrant positions in Q2 2022 and 2 closed out, a net change of +1 holder.
- The largest Peak Bio, Inc. Warrant buyer in Q2 2022 was Yakira Capital Management, an estimated $7.98K added.
- The largest Peak Bio, Inc. Warrant seller in Q2 2022 was Picton Mahoney Asset Management, an estimated $9K sold.
Based on aggregated 13F filings for Q2 2022.